Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Patrick Hugh ConwayCEO of Optum | -686,86 | 274,38k | Sale to Issuer | 399,47 | 6,50k | -9,56% |
| 2026-06-03 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -134,02 | 50,53k | Sale to Issuer | 377,00 | 16,58k | -0,80% |
| 2026-06-02 | Dr. Patrick Hugh ConwayCEO of Optum | -203,82 | 77,03k | Sale to Issuer | 377,92 | 7,19k | -2,76% |
| 2026-04-23 | Dr. Patrick Hugh ConwayCEO of Optum | -800,00 | 284,00k | Vendita | 355,00 | 6,98k | -10,28% |
| 2026-02-23 | Mr. Thomas Edward RoosInsider | -151,78 | 42,85k | Sale to Issuer | 282,34 | 31,28k | -0,48% |
| 2026-02-23 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -123,17 | 34,78k | Sale to Issuer | 282,34 | 17,47k | -0,70% |
| 2026-02-23 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -129,45 | 36,55k | Sale to Issuer | 282,34 | 16,63k | -0,77% |
| 2026-02-23 | Ms. Erin L. McSweeneyExec. VP & CPO | -130,68 | 36,90k | Sale to Issuer | 282,34 | 15,49k | -0,84% |
| 2026-02-23 | Dr. Patrick Hugh ConwayCEO of Optum | -178,99 | 50,54k | Sale to Issuer | 282,34 | 7,78k | -2,25% |
| 2026-02-20 | Ms. Erin L. McSweeneyExec. VP & CPO | -291,82 | 84,63k | Sale to Issuer | 290,00 | 10,75k | -2,64% |
| 2026-02-20 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -443,29 | 128,55k | Sale to Issuer | 290,00 | 9,67k | -4,38% |
| 2026-02-20 | Dr. Patrick Hugh ConwayCEO of Optum | -504,55 | 146,32k | Sale to Issuer | 290,00 | 7,96k | -5,96% |
| 2026-02-20 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -464,56 | 134,72k | Sale to Issuer | 290,00 | 8,74k | -5,05% |
| 2026-02-20 | Mr. Thomas Edward RoosInsider | -326,07 | 94,56k | Sale to Issuer | 290,00 | 29,00k | -1,11% |
| 2026-02-13 | Ms. Erin L. McSweeneyExec. VP & CPO | -153,09 | 44,89k | Sale to Issuer | 293,19 | 11,04k | -1,37% |
| 2026-02-13 | Mr. Thomas Edward RoosInsider | -321,89 | 94,37k | Sale to Issuer | 293,19 | 29,33k | -1,09% |
| 2026-02-13 | Dr. Patrick Hugh ConwayCEO of Optum | -295,41 | 86,61k | Sale to Issuer | 293,19 | 8,46k | -3,37% |
| 2026-02-13 | Mr. Timothy John NoelCEO of UnitedHealthcare Business | -125,62 | 36,83k | Sale to Issuer | 293,19 | 9,21k | -1,35% |
| 2026-02-13 | Mr. Christopher R. ZaettaExec. VP, Chief Legal Officer & Corporate Secretary | -212,52 | 62,31k | Sale to Issuer | 293,19 | 10,12k | -2,06% |
| 2025-12-19 | Mr. Stephen J. HemsleyCEO & Non-Independent Non-Executive Chairman | -55,00k | 0,00 | Other Disposition | - | 1,06M | -4,95% |
| 2025-09-11 | Mr. Charles Duane BakerIndependent Director | -27,00 | 9,61k | Vendita | 356,05 | 0,00 | -100,00% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
